Activation of DNA-PKcs in response to DSBs is relatively well understood and higher levels of DNA-PKcs expression have been reported in various tumor types including CRC, linking them to tumor pathogenesis and tumor progression, [45–49]. Here, PRKDC is linked to colorectal carcinoma.